Research programme: iminosugar antivirals - United Therapeutics

Drug Profile

Research programme: iminosugar antivirals - United Therapeutics

Alternative Names: Glycobiology antiviral agents; Iminosugar antivirals - United Therapeutics

Latest Information Update: 03 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Synergy Pharmaceuticals; University of Oxford
  • Developer United Therapeutics Corporation
  • Class Imino sugars; Small molecules
  • Mechanism of Action Hepatitis B virus replication inhibitors; Hepatitis C virus replication inhibitors; Virus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Dengue; Encephalitis virus infections; Hepatitis B; Hepatitis C

Most Recent Events

  • 05 Mar 2014 Preclinical development is ongoing in USA
  • 11 Mar 2010 Preclinical development is ongoing in USA
  • 08 Nov 2006 Preclinical development still in progress for Hepatitis B/C, dengue fever and Japanese encephalitis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top